North America CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Country: Trend Forecast and Growth Opportunity

February 2022 | 118 pages | ID: N6BF6A77B582EN
GMD Research

Abstracts

North America CRISPR Gene Editing market is projected to grow by 24.4% annually in the forecast period and reach $5,976.7 million by 2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic.

Highlighted with 28 tables and 50 figures, this 118-page report “North America CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America CRISPR Gene Editing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America CRISPR Gene Editing market in every aspect of the classification from perspectives of Offering, Application, End User, and Country.

Based on Offering, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• CRISPR Products
• Kits & Enzymes
• Vector-Based Cas9
• DNA-Free Cas9
• Databases & Libraries
• Design Tools
• Antibodies
• CRISPR Plasmid & Vector
• Other Products
• CRISPR Services
• gRNA Design & Vector Construction
• Cell Line Engineering
• Microbial Gene Editing
• DNA Synthesis
• Other Services

Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Biomedical Research & Therapy
• Gene Therapy
• Drug Discovery
• Diagnostics
• Other Biomedical Applications
• Agriculture
• Industrial Use
• Other Applications

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Pharmaceutical Companies
• Biotechnology Companies
• Academic Institutions & Research Centers
• Other End Users

Geographically, the following national/local markets are fully investigated:

• U.S.
• Canada
• Mexico

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of key national markets by Offering, Application, and End User, over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abcam, Inc.

Agilent Technologies, Inc.

Applied StemCell, Inc.

Caribou Biosciences, Inc.

Cellecta, Inc.

CRISPR Therapeutics AG

Editas Medicine, Inc.

GeneCopoeia, Inc.

GeneScript Biotech Corporation

Horizon Discovery Group PLC

Integrated DNA Technologies, Inc.

Intellia Therapeutics Inc.

Lonza Group Ltd.

Merck KGaA

New England Biolabs, Inc.

Origene Technologies, Inc.

Rockland Immunochemicals, Inc.

Synthego Corporation

System Biosciences LLC

Takara Bio, Inc.

Thermo Fisher Scientific, Inc.

ToolGen, Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF NORTH AMERICA MARKET BY OFFERING

3.1 Market Overview by Offering
3.2 CRISPR Products
  3.2.1 Kits & Enzymes
  3.2.2 Databases & Libraries
  3.2.3 Design Tools
  3.2.4 Antibodies
  3.2.5 CRISPR Plasmid & Vector
  3.2.6 Other Products
3.3 CRISPR Services
  3.3.1 gRNA Design & Vector Construction
  3.3.2 Cell Line Engineering
  3.3.3 Microbial Gene Editing
  3.3.4 DNA Synthesis
  3.3.5 Other Services

4 SEGMENTATION OF NORTH AMERICA MARKET BY APPLICATION

4.1 Market Overview by Application
4.2 Biomedical Research & Therapy
  4.2.1 Gene Therapy
  4.2.2 Drug Discovery
  4.2.3 Diagnostics
  4.2.4 Other Biomedical Applications
4.3 Agriculture
4.4 Industrial Use
4.5 Other Applications

5 SEGMENTATION OF NORTH AMERICA MARKET BY END USER

5.1 Market Overview by End User
5.2 Pharmaceutical Companies
5.3 Biotechnology Companies
5.4 Academic Institutions & Research Centers
5.5 Other End Users

6 NORTH AMERICA MARKET 2021-2031 BY COUNTRY

6.1 Overview of North America Market
6.2 U.S.
6.3 Canada
6.4 Mexico

7 COMPETITIVE LANDSCAPE

7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
Abcam, Inc.
Agilent Technologies, Inc.
Applied StemCell, Inc.
Caribou Biosciences, Inc.
Cellecta, Inc.
CRISPR Therapeutics AG
Editas Medicine, Inc.
GeneCopoeia, Inc.
GeneScript Biotech Corporation
Horizon Discovery Group PLC
Integrated DNA Technologies, Inc.
Intellia Therapeutics Inc.
Lonza Group Ltd.
Merck KGaA
New England Biolabs, Inc.
Origene Technologies, Inc.
Rockland Immunochemicals, Inc.
Synthego Corporation
System Biosciences LLC
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
ToolGen, Inc.
RELATED REPORTS

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of North America CRISPR Gene Editing Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. Developing Roadmap of CRISPR Technology
Table 4. Private and Public Companies Investment in CRISPR Technology
Table 5. Comparison of CRISPR with Other Gene Editing Technologies
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Main Product Trends and Market Opportunities in North America CRISPR Gene Editing Market
Table 8. North America CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 9. North America CRISPR Gene Editing Market: CRISPR Products by Type, 2021-2031, $ mn
Table 10. North America CRISPR Gene Editing Market: Kits & Enzymes by Type, 2021-2031, $ mn
Table 11. North America CRISPR Gene Editing Market: CRISPR Services by Type, 2021-2031, $ mn
Table 12. North America CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 13. North America CRISPR Gene Editing Market: Biomedical Research & Therapy by Type, 2021-2031, $ mn
Table 14. North America CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 15. North America CRISPR Gene Editing Market by Country, 2021-2031, $ mn
Table 16. U.S. CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 17. U.S. CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 18. U.S. CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 19. Canada CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 20. Canada CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 21. Canada CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 22. Mexico CRISPR Gene Editing Market by Offering, 2021-2031, $ mn
Table 23. Mexico CRISPR Gene Editing Market by Application, 2021-2031, $ mn
Table 24. Mexico CRISPR Gene Editing Market by End User, 2021-2031, $ mn
Table 25. Breakdown of World Market by Key Vendor, 2021, %
Table 26. Abcam, Inc.: Company Snapshot
Table 27. Abcam, Inc.: Business Segmentation
Table 28. Abcam, Inc.: Product Portfolio

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. North America CRISPR Gene Editing Market, 2021-2031, $ mn
Figure 5. Categories of CRISPR-Cas Systems
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of North America CRISPR Gene Editing Market
Figure 8. Leading Causes of Death in the World, 2019-2020, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of North America CRISPR Gene Editing Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of North America CRISPR Gene Editing Market
Figure 14. Breakdown of North America CRISPR Gene Editing Market by Offering, 2021-2031, % of Revenue
Figure 15. North America Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%)
Figure 16. North America CRISPR Gene Editing Market by Offering: CRISPR Products, 2021-2031, $ mn
Figure 17. North America CRISPR Gene Editing Market by CRISPR Products: Kits & Enzymes, 2021-2031, $ mn
Figure 18. North America CRISPR Gene Editing Market by CRISPR Products: Databases & Libraries, 2021-2031, $ mn
Figure 19. North America CRISPR Gene Editing Market by CRISPR Products: Design Tools, 2021-2031, $ mn
Figure 20. North America CRISPR Gene Editing Market by CRISPR Products: Antibodies, 2021-2031, $ mn
Figure 21. North America CRISPR Gene Editing Market by CRISPR Products: CRISPR Plasmid & Vector, 2021-2031, $ mn
Figure 22. North America CRISPR Gene Editing Market by CRISPR Products: Other Products, 2021-2031, $ mn
Figure 23. North America CRISPR Gene Editing Market by Offering: CRISPR Services, 2021-2031, $ mn
Figure 24. North America CRISPR Gene Editing Market by CRISPR Services: gRNA Design & Vector Construction, 2021-2031, $ mn
Figure 25. North America CRISPR Gene Editing Market by CRISPR Services: Cell Line Engineering, 2021-2031, $ mn
Figure 26. North America CRISPR Gene Editing Market by CRISPR Services: Microbial Gene Editing, 2021-2031, $ mn
Figure 27. North America CRISPR Gene Editing Market by CRISPR Services: DNA Synthesis, 2021-2031, $ mn
Figure 28. North America CRISPR Gene Editing Market by CRISPR Services: Other Services, 2021-2031, $ mn
Figure 29. Breakdown of North America CRISPR Gene Editing Market by Application, 2021-2031, % of Sales Revenue
Figure 30. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 31. North America CRISPR Gene Editing Market by Application: Biomedical Research & Therapy, 2021-2031, $ mn
Figure 32. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Gene Therapy, 2021-2031, $ mn
Figure 33. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Drug Discovery, 2021-2031, $ mn
Figure 34. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Diagnostics, 2021-2031, $ mn
Figure 35. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Other Biomedical Applications, 2021-2031, $ mn
Figure 36. North America CRISPR Gene Editing Market by Application: Agriculture, 2021-2031, $ mn
Figure 37. North America CRISPR Gene Editing Market by Application: Industrial Use, 2021-2031, $ mn
Figure 38. North America CRISPR Gene Editing Market by Application: Other Applications, 2021-2031, $ mn
Figure 39. Breakdown of North America CRISPR Gene Editing Market by End User, 2021-2031, % of Sales Revenue
Figure 40. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 41. North America CRISPR Gene Editing Market by End User: Pharmaceutical Companies, 2021-2031, $ mn
Figure 42. North America CRISPR Gene Editing Market by End User: Biotechnology Companies, 2021-2031, $ mn
Figure 43. North America CRISPR Gene Editing Market by End User: Academic Institutions & Research Centers, 2021-2031, $ mn
Figure 44. North America CRISPR Gene Editing Market by End User: Other End Users, 2021-2031, $ mn
Figure 45. Breakdown of North America CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue
Figure 46. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 47. U.S. CRISPR Gene Editing Market, 2021-2031, $ mn
Figure 48. Canada CRISPR Gene Editing Market, 2021-2031, $ mn
Figure 49. CRISPR Gene Editing Market in Mexico, 2021-2031, $ mn
Figure 50. Growth Stage of North America CRISPR Gene Editing Industry over the Forecast Period